Diabetes

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

FDA warns of genital gangrene risk with diabetes drug class

https://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

J&J seals $2.1bn deal on sale of major diabetes devices firm

https://pharmaphorum.com/news/jj-deal-glucose-monitoring-system/

As competition hots up, J&J exits insulin pump market

https://pharmaphorum.com/news/animas-insulin-pump-north-america/

Automatic artificial pancreas shows promise in trial

https://pharmaphorum.com/news/automatic-artificial-pancreas/

ADA to re-evaluate tweet ban after backlash

https://pharmaphorum.com/news/ada-re-evaluate-tweet-ban-backlash/

Close in 10 seconds

Pharmaphorum.com

Search